AmInvestment upgrades earnings outlook on Berjaya Food

KUALA LUMPUR: AmInvestment Bank Research raised its earnings forecasts on Berjaya Food Bhd due to higher-than-expected sales and operating profit margin resulting from the cost-cutting measures in 1QFY21.

The research house, which has a "hold" recommendation on the stock, said Berjaya Food's core net profit of RM10.4mil exceeded its and consensus estimates at 78.7% and 51% of full-year estimates respectively.

"This was due to the group’s effective cost management implemented to mitigate the impact of the pandemic and improved performance from Kenny Rogers Roasters (KRR) after the closure of non-performing stores in FY20," it said.

Revenue for the quarter meanwhile came in at RM180.7mil which was 23.9% and 24.2% of AmInvestment's and consensus estimates, which was comparable to that of the previous corresponding quarter, suggesting that revenue had returned to pre-Covid-19 levels.

AmInvestment expects Berjaya Food's 2QFY21 sales to only be marginally impacted by the reimplementation of the CMCO.

"2Q is usually BFood’s best performing quarter due to the holiday season. Also, economic activities are still continuing, which means stores remain open in contrast to the MCO period," it said.

"Moving forward, we believe BFood’s sales growth would be driven largely by the recovery in SSSG as the Covid-19 situation improves.

"We expect earnings to normalize at the end of the CMCO period and new store openings would also drive sales for the group. BFood plans to open an additional 12 Starbucks stores and 5 ssKRR stores in FY21F," it added.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

Next In Business News

Grab considering secondary Singapore listing after US SPAC merger - sources
UEM Edgenta denies allegations, claims against its subsidiary by AZSB
Bank Negara revises foreign exchange notices
Tencent raises US$4.2bil in its second major bond deal in a year
World stocks near record highs as China, U.S. data back global recovery hopes
Oil steady climbs to four-week high on strong China data, demand revival
Sinopharm to inject US$4.6 bln vaccine assets into unit Tiantan Biological
China's GDP hits record growth but post-Covid recovery seen losing steam
20 new international destinations expected to boost air travel for MAHB airports
FBM KLCI en route to end week on slightly weaker footing

Stories You'll Enjoy